![]() |
Name |
N-(2-Ethoxyphenyl)acetamide
|
Molecular Formula | C10H13NO2 | |
IUPAC Name* |
N-(2-ethoxyphenyl)acetamide
|
|
SMILES |
CCOC1=CC=CC=C1NC(=O)C
|
|
InChI |
InChI=1S/C10H13NO2/c1-3-13-10-7-5-4-6-9(10)11-8(2)12/h4-7H,3H2,1-2H3,(H,11,12)
|
|
InChIKey |
SQRTWLGWCOJOTO-UHFFFAOYSA-N
|
|
Synonyms |
N-(2-Ethoxyphenyl)acetamide; 581-08-8; N-Acetyl-o-phenetidine; 2'-Ethoxyacetanilide; o-Acetylphenetidine; Acetamide, N-(2-ethoxyphenyl)-; 2-Ethoxyacetanilide; o-ACETOPHENETIDIDE; Acetanilide, 2'-ethoxy-; NSC 7649; o-Ethoxyacetanilide; OF0OT3R0XB; NSC-7649; EINECS 209-460-9; N-Acetyl-2-ethoxyaniline; BRN 2720676; AI3-00787; N-(2-Ethoxy-phenyl)-acetamide; NSC7649; Azetamidophenylathylather; UNII-OF0OT3R0XB; ChemDiv2_000587; o-Phenetidine, N-acetyl-; Cambridge id 5104364; WLN: 2OR BMV1; Aniline, N-acetyl-2-ethoxy-; N-(2-Ethoxyphenyl)-acetamide; SCHEMBL1645837; DTXSID7060382; ZINC30083; HMS1370K15; MFCD00059228; STK000709; AKOS000508149; AS-59116; A0103; CS-0453866; FT-0694813; D88214; A831741; AG-669/02953017
|
|
CAS | 581-08-8 | |
PubChem CID | 11383 | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 179.22 | ALogp: | 1.5 |
HBD: | 1 | HBA: | 2 |
Rotatable Bonds: | 3 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 38.3 | Aromatic Rings: | 1 |
Heavy Atoms: | 13 | QED Weighted: | 0.774 |
Caco-2 Permeability: | -4.21 | MDCK Permeability: | 0.00003120 |
Pgp-inhibitor: | 0.008 | Pgp-substrate: | 0.317 |
Human Intestinal Absorption (HIA): | 0.003 | 20% Bioavailability (F20%): | 0.003 |
30% Bioavailability (F30%): | 0.961 |
Blood-Brain-Barrier Penetration (BBB): | 0.463 | Plasma Protein Binding (PPB): | 27.17% |
Volume Distribution (VD): | 0.962 | Fu: | 48.19% |
CYP1A2-inhibitor: | 0.952 | CYP1A2-substrate: | 0.944 |
CYP2C19-inhibitor: | 0.421 | CYP2C19-substrate: | 0.863 |
CYP2C9-inhibitor: | 0.069 | CYP2C9-substrate: | 0.793 |
CYP2D6-inhibitor: | 0.014 | CYP2D6-substrate: | 0.787 |
CYP3A4-inhibitor: | 0.028 | CYP3A4-substrate: | 0.601 |
Clearance (CL): | 6.324 | Half-life (T1/2): | 0.807 |
hERG Blockers: | 0.05 | Human Hepatotoxicity (H-HT): | 0.308 |
Drug-inuced Liver Injury (DILI): | 0.873 | AMES Toxicity: | 0.402 |
Rat Oral Acute Toxicity: | 0.032 | Maximum Recommended Daily Dose: | 0.015 |
Skin Sensitization: | 0.385 | Carcinogencity: | 0.561 |
Eye Corrosion: | 0.004 | Eye Irritation: | 0.718 |
Respiratory Toxicity: | 0.026 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC000106 | ![]() |
0.500 | D06LYG | ![]() |
0.404 | ||
ENC002891 | ![]() |
0.449 | D0GY5Z | ![]() |
0.392 | ||
ENC002235 | ![]() |
0.440 | D0U5QK | ![]() |
0.347 | ||
ENC002213 | ![]() |
0.420 | D0V9JR | ![]() |
0.344 | ||
ENC000823 | ![]() |
0.412 | D0FN7J | ![]() |
0.339 | ||
ENC000160 | ![]() |
0.408 | D08GJO | ![]() |
0.333 | ||
ENC000370 | ![]() |
0.404 | D0T3NY | ![]() |
0.328 | ||
ENC000175 | ![]() |
0.396 | D0N3UL | ![]() |
0.327 | ||
ENC000073 | ![]() |
0.392 | D05OFX | ![]() |
0.323 | ||
ENC000693 | ![]() |
0.373 | D07ESC | ![]() |
0.323 |